Pankhuri Malik is an IPilogue Writer, IP Innovation Clinic Fellow, and an LLM Candidate at Osgoode Hall Law School. On May 31, 2022, the Federal Court of Canada ruled in…
Tag: medicine
The Competition Bureau And Health Canada Issue Joint Notice On Continued Collaboration In Pharmaceutical Sector
M. Imtiaz Karamat is an IP Osgoode Alumnus and Associate Lawyer at Deeth Williams Wall LLP. This article was originally posted on E-TIPS™ For Deeth Williams Wall LLP on January 26,…
Evolving Perspectives: USPTO Call for Comments on Patent Eligibility Comes to a Close (Part 1)
Meena Alnajar is an IPilogue Writer, IP Innovation Clinic Fellow, and a 2L JD Candidate at Osgoode Hall Law School On October 15, 2021, the U.S Patent and Trademarks Office (USPTO) closed the public comment…
Insulin Biohackers: Shaking Up a Billion-Dollar Industry
Natalie Bravo is an IPilogue Writer and a 2L JD Candidate at Osgoode Hall Law School. Brief History of Insulin In 1921, Dr. Frederick Banting, Charles Best, and James…
A Win for Patent Law and a Loss for Prostate Cancer
Photo Credits: healthline.com (https://www.healthline.com/health/cancer/cancer-ribbon-colors) Shawn Dhue is an IPilogue Writer and a 2L JD Candidate at Osgoode Hall Law School. Janssen Inc. (“Janssen”), a Canadian pharmaceutical company, sells ZYTIGA under Patent No. 2,661,422 (“422 Patent”).…
in Access to Medicines, Commercialization, Design, Development, IP, Patentability, Patents, Pharmaceutical Drugs, Uncategorized0by Editor
2028
What Makes It My Molecule: A Look at Professor Ronald Pearlman’s Genome Editing Work
This past November, Professor Ronald E. Pearlman from York University’s Department of Biology gave a talk [1] at Osgoode Hall Law School to discuss the potential of the innovative CRISPR…